404 related articles for article (PubMed ID: 8962549)
1. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.
Woodfield SL; Lundergan CF; Reiner JS; Greenhouse SW; Thompson MA; Rohrbeck SC; Deychak Y; Simoons ML; Califf RM; Topol EJ; Ross AM
J Am Coll Cardiol; 1996 Dec; 28(7):1661-9. PubMed ID: 8962549
[TBL] [Abstract][Full Text] [Related]
2. Gender and acute myocardial infarction: is there a different response to thrombolysis?
Woodfield SL; Lundergan CF; Reiner JS; Thompson MA; Rohrbeck SC; Deychak Y; Smith JO; Burton JR; McCarthy WF; Califf RM; White HD; Weaver WD; Topol EJ; Ross AM
J Am Coll Cardiol; 1997 Jan; 29(1):35-42. PubMed ID: 8996292
[TBL] [Abstract][Full Text] [Related]
3. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM
J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.
Granger CB; Califf RM; Young S; Candela R; Samaha J; Worley S; Kereiakes DJ; Topol EJ
J Am Coll Cardiol; 1993 Mar; 21(4):920-5. PubMed ID: 8450161
[TBL] [Abstract][Full Text] [Related]
5. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM
Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348
[TBL] [Abstract][Full Text] [Related]
6. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
Goodman SG; Langer A; Ross AM; Wildermann NM; Barbagelata A; Sgarbossa EB; Wagner GS; Granger CB; Califf RM; Topol EJ; Simoons ML; Armstrong PW
Circulation; 1998 Feb; 97(5):444-50. PubMed ID: 9490238
[TBL] [Abstract][Full Text] [Related]
7. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.
Singh N; Mironov D; Armstrong PW; Ross AM; Langer A
Circulation; 1996 Apr; 93(7):1388-95. PubMed ID: 8641028
[TBL] [Abstract][Full Text] [Related]
8. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Mak KH; Moliterno DJ; Granger CB; Miller DP; White HD; Wilcox RG; Califf RM; Topol EJ
J Am Coll Cardiol; 1997 Jul; 30(1):171-9. PubMed ID: 9207639
[TBL] [Abstract][Full Text] [Related]
9. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
[TBL] [Abstract][Full Text] [Related]
10. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Lundergan CF; Reiner JS; McCarthy WF; Coyne KS; Califf RM; Ross AM
J Am Coll Cardiol; 1998 Sep; 32(3):641-7. PubMed ID: 9741505
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
[TBL] [Abstract][Full Text] [Related]
12. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
[TBL] [Abstract][Full Text] [Related]
14. Early T wave inversion after thrombolytic therapy predicts better coronary perfusion: clinical and angiographic study.
Matetzky S; Barabash GI; Shahar A; Rabinowitz B; Rath S; Zahav YH; Agranat O; Kaplinsky E; Hod H
J Am Coll Cardiol; 1994 Aug; 24(2):378-83. PubMed ID: 8034871
[TBL] [Abstract][Full Text] [Related]
15. Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Reiner JS; Lundergan CF; van den Brand M; Boland J; Thompson MA; Machecourt J; Py A; Pilcher GS; Fink CA; Burton JR
J Am Coll Cardiol; 1994 Nov; 24(6):1439-44. PubMed ID: 7930273
[TBL] [Abstract][Full Text] [Related]
16. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
GUSTO Angiographic Investigators
N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
[TBL] [Abstract][Full Text] [Related]
17. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
Wackers FJ; Terrin ML; Kayden DS; Knatterud G; Forman S; Braunwald E; Zaret BL
J Am Coll Cardiol; 1989 Apr; 13(5):998-1005. PubMed ID: 2494246
[TBL] [Abstract][Full Text] [Related]
18. Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty.
Abbottsmith CW; Topol EJ; George BS; Stack RS; Kereiakes DJ; Candela RJ; Anderson LC; Harrelson-Woodlief SL; Califf RM
J Am Coll Cardiol; 1990 Oct; 16(4):770-8. PubMed ID: 1698843
[TBL] [Abstract][Full Text] [Related]
19. Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experience.
Lundergan CF; Ross AM; McCarthy WF; Reiner JS; Boyle D; Fink C; Califf RM; Topol EJ; Simoons ML; Van Den Brand M; Van de Werf F; Coyne KS;
Am Heart J; 2001 Jul; 142(1):43-50. PubMed ID: 11431655
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
